XTANT MEDICAL HOLDINGS, INC. (XTNT) Return on equity 2020–2025
XTANT MEDICAL HOLDINGS, INC. (XTNT) return on equity by fiscal year — reported net income divided by year-end shareholders’ equity.
9.8%FY2025 · since FY2020: -48.4% → 9.8%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | 9.8% | +48.0 pp |
| FY2024 | -38.3% | -39.6 pp |
| FY2023 | 1.3% | +26.1 pp |
| FY2022 | -24.8% | -9.1 pp |
| FY2021 | -15.7% | +32.7 pp |
| FY2020 | -48.4% | — |
ROE = reported net income ÷ reported year-end shareholders’ equity for the same fiscal year. Heavy buybacks shrink equity and can push ROE very high (or negative-equity years drop out).
Source: SEC XBRL filings · For reference only · Not investment advice